Conference scene: Pharmacogenomics at the second PharmSciFair 2009: Adverse drug reactions and clinical implementation

Pharmacogenomics

Volumn 10, Issue 9, 2009, Pages 1389-1391

  Van Schie, Rianne M F ^a   Cascorbi, Ingolf ^b   Maitland Van Der Zee, Anke Hilse ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTINEOPLASTIC AGENT; CORTICOSTEROID; COUMARIN DERIVATIVE; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DRUG METABOLIZING ENZYME; FLUCLOXACILLIN; HLA ANTIGEN; MERCAPTOPURINE; PROTEIN VKORC1; RISPERIDONE; UNCLASSIFIED DRUG; WARFARIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ASTHMA; BIOCHIP; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; DRUG TARGETING; FRANCE; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE PLANNING; HEALTH EDUCATION; HUMAN; INTERMETHOD COMPARISON; LIVER INJURY; LOADING DRUG DOSE; PHARMACOGENOMICS; PREDICTION; PUBLICATION; SCHIZOPHRENIA; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; UNSPECIFIED SIDE EFFECT;

DRUG THERAPY; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS;

EID: 70649094354     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.09.95     Document Type: Conference Paper

References (3)

1. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, Group HS: Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands. Arch. Intern. Med. 168, 1890-1896 (2008).
2. Daly A, Donaldson P, Bhatnagar P et al.: HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41(7), 816-819 (2009).
3. Koster ES, Raaijmakers JAM, Koppelman GH et al.: Pharmacogenetics of antiinflammatory treatment in children with asthma: Rationale and design of the PACMAN cohort. Pharmacogenomics 10(8), 1351-1361 (2009).